Bookmark us
 
 
 

AltebrelTM
is a biosimilar product with the generic name of Etanercept. It is used for treatment of several autoimmune diseases like Rheumatoid Arthritis, Plaque Psoriasis, Psoriasis Arthritis, Spondyloarthritis, Ankylosing Spondylitis and Juvenile Idiopathic.

Etanercept is a fusion protein consisting of FC part of antibodies and two TNF receptors. Etanercept is a homodimeric protein. Each monomer is composed of an extracellular receptor part which is banded to human TNFα with FC part of immunoglobulin IgG1.

Etanercept manufacturing is based on expression by a protein recombinant technology using Chinese Hamster Ovary (CHO) cell. This molecule is composed of 934 amino acids with weight of 150 KDa and acts as a TNFα Blocker. TNFα is a kind of cytokine which is produced by monocytes and macrophages and increases white cells flow to the site of inflammation. According to this function and some other related mechanisms, TNFα could increase inflammation. So, Etanercept decreases inflammation responses through inhibiting the mentioned TNFα mechanism which is completely effective in treatment of autoimmune diseases.

This medicine is produced as prefilled syringes containing solution form with two different dosages: 25 mg and 50 mg. For more information visit us   at  www.Altebrel.com

   
       
 
 

Active Raw Material (API) of Altebrel with the name of Etanercept is being purified via several pre-purification and purification steps by chromatography methods for use in final formulation.



Download Leaflet of AltebrelTM


Download HCP of AltebrelTM